Bioventus Inc. (BVS)

Bioventus Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	748	332	162	861	-	-
Market Cap Growth	266.18%	105.22%	-81.23%	-	-	-
Enterprise Value	1,146	775	605	1,054	-	-
Last Close Price	11.41	5.27	2.61	14.49	-	-
Forward PE	19.09	21.82	17.17	21.50	-	-
PS Ratio	1.31	0.65	0.32	2.00	-	-
PB Ratio	5.01	1.50	0.39	1.61	-	-
P/FCF Ratio	25.68	41.57	-	90.94	-	-
P/OCF Ratio	24.99	21.63	-	37.46	-	-
PEG Ratio	-	-	-	2.07	-	-
EV/Sales Ratio	2.06	1.51	1.18	2.45	-	-
EV/EBITDA Ratio	22.74	26.88	-	25.38	-	-
EV/EBIT Ratio	36.60	382.69	-	50.07	-	-
EV/FCF Ratio	39.45	97.14	-	111.28	-	-
Debt / Equity Ratio	2.17	1.90	1.06	0.70	1.42	1.48
Debt / EBITDA Ratio	7.15	11.81	719.64	8.23	3.83	3.69
Debt / FCF Ratio	13.95	52.70	-	39.72	3.70	5.63
Asset Turnover	0.70	0.47	0.39	0.50	0.66	0.74
Inventory Turnover	1.95	2.09	2.47	2.82	3.11	3.32
Quick Ratio	0.78	0.91	0.55	0.93	1.43	1.68
Current Ratio	1.41	1.53	0.90	1.45	1.73	2.06
Return on Equity (ROE)	-24.76%	-38.27%	-30.58%	3.38%	10.16%	5.58%
Return on Assets (ROA)	2.48%	0.12%	-1.67%	1.53%	2.82%	4.34%
Return on Capital (ROIC)	3.16%	0.17%	-2.46%	2.09%	3.84%	5.66%
Earnings Yield	-5.29%	-47.08%	-98.15%	2.25%	-	-
FCF Yield	3.89%	2.41%	-14.58%	1.10%	-	-
Payout Ratio	0.00%	-	-	-	121.17%	-
Buyback Yield / Dilution	-2.56%	-2.05%	-35.00%	-828.01%	-	-
Total Shareholder Return	-2.56%	-2.05%	-35.00%	-828.01%	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.